Literature DB >> 12847600

Prostate specific antigen reference ranges in Saudi men.

Baher A Kamal1, Gaber A Ali, Saud A Taha.   

Abstract

OBJECTIVE: The aim of this study is to find out the age-specific and population-specific values of prostate specific antigen (PSA) among Saudi men. Normal values for different age groups between 40 and 89 years will be obtained.
METHODS: The study was conducted in King Fahd Hospital of the University, Al-Khobar, Kingdom of Saudi Arabia. The total free and percent free PSA were measured for Saudi men who were free of prostate cancer by digital rectal examination (DRE) and with PSA value of <4 ng/ml. Transrectal ultrasonography and needle biopsy were performed in those with suspicious DRE or PSA >4 ng/ml. A total of 567 cancer free Saudi men were included in this study. All men were divided into 5 groups; each 10 years interval starting from the age of 40 years.
RESULTS: The mean values of total PSA were 0.87 for men 40-49 years, 1.36 for men 50-59 years, 1.81 for men 60-69 years, 2.32 for men 70-79 years and 2.36 for men 80-89 years. The percent free PSA was >30% in all age groups. When those with PSA <4 ng/ml were considered, the percent free PSA was the same and only 16.6% of them had a ratio of < or =18%. The upper limit of normal PSA was near to that of Chinese and Korean.
CONCLUSION: Normal mean PSA values for Saudi men are lower than the reported values. The percent free PSA for men having PSA <4 ng/ml is applicable. Racial variations of PSA values were observed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847600

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  6 in total

1.  Differences in prostate cancer detection between Canadian and Saudi populations.

Authors:  O Z Al-Abdin; D M Rabah; G Badr; A Kotb; A Aprikian
Journal:  Braz J Med Biol Res       Date:  2013-06-25       Impact factor: 2.590

Review 2.  With increasing trends of prostate cancer in the Saudi Arabia and Arab World: Should we start screening programs?

Authors:  Mostafa A Arafa; Danny M Rabah
Journal:  World J Clin Oncol       Date:  2017-12-10

3.  Prostate cancer in Asia: A collaborative report.

Authors:  Rui Chen; Shancheng Ren; Ming Kwong Yiu; Ng Chi Fai; Wai Sam Cheng; Lap Hong Ian; Seiji Naito; Tadashi Matsuda; Elijah Kehinde; Ali Kural; Jason Yichun Chiu; Rainy Umbas; Qiang Wei; Xiaolei Shi; Liqun Zhou; Jian Huang; Yiran Huang; Liping Xie; Lulin Ma; Changjun Yin; Danfeng Xu; Kexin Xu; Zhangqun Ye; Chunxiao Liu; Dingwei Ye; Xin Gao; Qiang Fu; Jianquan Hou; Jianlin Yuan; Dalin He; Tiejun Pan; Qiang Ding; Fengshuo Jin; Benkang Shi; Gongxian Wang; Xiuheng Liu; Dongwen Wang; Zhoujun Shen; Xiangbo Kong; Wanhai Xu; Yaoliang Deng; Haibo Xia; Alexa N Cohen; Xu Gao; Chuanliang Xu; Yinghao Sun
Journal:  Asian J Urol       Date:  2015-04-16

4.  Prostate cancer in the Arab population. An overview.

Authors:  Osman Z Al-Abdin; Ibrahim Z Al-Beeshi
Journal:  Saudi Med J       Date:  2018-05       Impact factor: 1.484

5.  Age-specific reference ranges of prostate-specific antigen in the elderly of Amirkola: A population-based study.

Authors:  Hosseini Seyed Reza; Zabihi Ali; Habibian Tara; Bijani Ali
Journal:  Asian J Urol       Date:  2020-03-07

6.  A hospital based study on reference range of serum prostate specific antigen levels.

Authors:  Aditi Gupta; Deepa Gupta; Arun Raizada; Narmada Prasad Gupta; Rajiv Yadav; Kamini Vinayak; Vijay Tewari
Journal:  Indian J Med Res       Date:  2014-10       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.